ENT2 Antibodies

Santa Cruz Biotechnology provides a broad selection of ENT2 monoclonal antibodies for advanced research in molecular biology. ENT2 monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ENT2, or Equilibrative Nucleoside Transporter 2, plays a critical role in the transport of nucleosides across cell membranes, influencing cellular metabolism and signaling pathways. The function of ENT2 is essential for maintaining nucleotide pools and regulating cellular responses to stress, making it a significant target for research in cancer, cardiovascular diseases, and neurobiology. Understanding ENT2 mechanisms can provide insights into therapeutic strategies for various conditions. Researchers worldwide rely on ENT2 monoclonal antibodies to advance their studies in nucleoside transport systems. Current investigations focus on how ENT2 influences drug delivery and therapeutic outcomes across different disease models. The development of targeted treatments depends on thorough characterization of ENT2 expression and activity patterns. Santa Cruz Biotechnology monoclonal antibodies support the scientific community in uncovering new therapeutic possibilities through precise and reliable ENT2 research.